AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PTCT
  4. [Form 4] PTC Therapeutics, Inc. Insider Trading Activity

[Form 4] PTC Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source:

Stock PTCT logo
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

#2081 Ranked by Market Cap
N/A Ranked by Dividends

PTCT Latest News

Aug 7, 2025
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Jul 28, 2025
PTC Therapeutics Announces FDA Approval of Sephience鈩� (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Jul 21, 2025
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results
Jun 23, 2025
Sephience鈩� (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Jun 19, 2025
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTCT Latest SEC Filings

Aug 7, 2025
[10-Q] PTC Therapeutics, Inc. Quarterly Earnings Report
Aug 7, 2025
[8-K] PTC Therapeutics, Inc. Reports Material Event
Aug 5, 2025
[Form 4] PTC Therapeutics, Inc. Insider Trading Activity
Aug 5, 2025
[144] PTC Therapeutics, Inc. SEC Filing
Jul 28, 2025
[8-K] PTC Therapeutics, Inc. Reports Material Event

PTCT Stock Data

4.05B
77.30M
2.4%
101.69%
7.28%
Biotechnology
Pharmaceutical Preparations
United States
WARREN